RNF165 Double Nickase Plasmid (h): sc-416077-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- RNF165 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- RNF165 Double Nickase Plasmid (h) and RNF165 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting RNF165. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RNF165 Double Nickase Plasmid (h) | sc-416077-NIC | 20 µg | $410.00 | |||
RNF165 Double Nickase Plasmid (h2) | sc-416077-NIC-2 | 20 µg | $410.00 |
RNF165 encodes a RING-type E3 ubiquitin ligase implicated in ubiquitin-dependent control of protein stability and signaling outputs in human cells. By catalyzing substrate ubiquitination, RNF165 is expected to influence proteostasis, stress-responsive pathways, and the amplitude and duration of signal transduction cascades that depend on regulated protein turnover. Dysregulation of E3 ligase activity and ubiquitin pathway components is broadly linked to altered cell cycle control, innate immune signaling, and oncogenic phenotypes, making RNF165 a useful node for mechanistic studies. Interrogating RNF165 function can help clarify how ubiquitin-mediated regulation shapes cellular homeostasis and context-dependent disease biology.
RNF165 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the RNF165 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within RNF165. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt RNF165 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of RNF165-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.